Andrew Alliance Webinar: Improving reproducibility of large-scale experiments by using a pipette+ system

NewsGuard 100/100 Score

CRISPR/ Cas9 has revolutionized how genetic screens are conducted, as the system is remarkably easy to implement into existing workflows while yielding high editing efficiency.  Large-scale screening experiments, e.g. knockout screens are particularly well suited for automation as many repeated workflow steps are required.  

The integration of a guided pipetting system such as Pipette+, results in fewer user-related errors, in 20% of the time normally required. Using the Pipette+ system of Andrew Alliance together with the cloud-native OneLab software, experiments can be quickly designed, executed, and fully tracked.

Karsten Krey, a researcher in the group of Prof Andreas Pichlmair, will present this study, supported by technical data.

You will learn how you can benefit from:

  • simpler, fully programmable guided pipetting
  • superior reproducibility
  • freeing up time to focus on higher-level tasks

The webinar is on the 10 December 2020

10 - 10:30 a.m. Eastern Daylight Time (EDT),
4 - 4:30 p.m. Central European Summer Time (CEST)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness